XML 40 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements and Short-Term Investments (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Short-term Investments Available-for-sale As of December 31, 2020, all of the Company’s investments had remaining maturities of less than 12 months. The following is a summary of the Company’s short-term investments, considered available-for-sale, as of December 31, 2020:
As of December 31, 2020
AmortizedGross UnrealizedEstimated
CostGainsLossesFair Value
Available-for-sale securities
U.S treasury securities$5,000 $— $— $5,000 
Schedule Assets and Liabilities Measured on Recurring Basis
The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The fair value of these instruments was as follows:
As of December 31, 2021
Fair ValueLevel 1Level 2Level 3
Liabilities
Contingent royalty obligation payable to Evolus Founders$44,740 $— $— $44,740 
As of December 31, 2020
Fair ValueLevel 1Level 2Level 3
Available-for-sale debt securities
U.S treasury securities$5,000 $5,000 $— $— 
Liabilities
Contingent royalty obligation payable to Evolus Founders$41,546 $— $— $41,546 
Schedule of Reconciliation of Fair Value Measurement for Contingent Royalty Obligation Payable
The following table shows a reconciliation of the beginning and ending fair value measurements of the contingent royalty obligation payable:
Year Ended December 31,
20212020
Fair value, beginning of period$41,546 $44,683 
Payments(3,097)(1,130)
Change in fair value recorded in operating expenses6,290 (2,007)
Fair value, end of period$44,740 $41,546